Company News

BIBP’s COVID-19 Vaccine Approved for Emergency Use in Lebanon

March 2 (www.haiwainet.cn)- On Monday (March 1) local time, a scientific committee set up by Hamad Hassan, Minister of Public Health of Lebanon Caretaker Cabinet, approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec GroupCompany Limited(CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for emergency use, Naharnet (a Lebanese news agency) reported.

     Earlier on March 2, CCTV News reported that according to the request of Lebanon, China decided to provide Lebanon with BIBP’s COVID-19 Vaccine to help Lebanon control the epidemic.